Search for Clinical Trial Results
Neurofibromatosis Type 2 - 25 Studies Found
Status | Study |
Completed |
Study Name: Analysis of NF2 Mutations in Radiation-Related Neural Tumors Condition: Neural Tumors Date: 2006-06-19 |
Recruiting |
Study Name: Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas Condition:
|
Recruiting |
Study Name: Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations Condition:
Date: 2015-01-28 Interventions: Drug: Everolimus Other Names:
|
Completed |
Study Name: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity Condition: Malignant Pleural Mesothelioma Date: 2009-12-02 Interventions: Drug: everolimus Everolimus will be administered at a dose of 10mg orally once daily continuously. Dose |
Recruiting |
Study Name: Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas Condition:
Interventions: Drug: RAD001 Other Name: Everolimus |